| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |